Russia and human immunodeficiency virus-beyond crime and punishment

Addiction

Volumn 106, Issue 11, 2011, Pages 1883-1885

  Samet, Jeffrey H ^a,b  

^a BOSTON MEDICAL CENTER   (United States)

^b BOSTON UNIVERSITY SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EDITORIAL; EPIDEMIC; HEALTH CARE POLICY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; RUSSIAN FEDERATION; SUBSTANCE ABUSE;

EPIDEMICS; HEALTH POLICY; HIV; HIV INFECTIONS; HUMANS; RUSSIA; SUBSTANCE ABUSE, INTRAVENOUS;

EID: 80053614656     PISSN: 09652140     EISSN: 13600443     Source Type: Journal    
DOI: 10.1111/j.1360-0443.2011.03523.x     Document Type: Editorial

References (19)

1. Holt E. Russian injected drug use soars in face of political inertia. Lancet 2010; 376: 13-4.
2. Mathers B. M., Degenhardt L., Adam P., Toskin I., Nashkhoev M., Lyerla R. etal. Estimating the level of HIV prevention coverage, knowledge and protective behavior among injecting drug users: what does the 2008 UNGASS reporting round tell us? J Acquir Immune Defic Syndr 2009; 52: S132-S142.
3. World Health Organization (WHO), United Nations Office on Drugs and Crime (UNODC), Joint United Nations Programme on HIV/AIDS (UNAIDS). Technical guide for countries to set targets for universal access to HIV prevention, treatment and care for injecting drug users. 2009. Available at: (accessed 31 March 2011; archived by Webcite at).
4. Joint United Nations Programme on HIV/AIDS (UNAIDS). Global Report: UNAIDS Report on the Global AIDS Epidemic, 2010. Joint United Nations Programme on HIV/AIDS. 2010. Available at: (accessed 17 May 2011; archived by Webcite at).
5. Niccolai L. M., Verevochkin S. V., Toussova O. V., White E., Barbour R., Kozlov A. P. etal. Estimates of HIV incidence among drug users in St. Petersburg, Russia: continued growth of a rapidly expanding epidemic. Eur J Public Health 2010; Epub ahead of print 26 August.
6. Niccolai L. M., Shcherbakova I. S., Toussova O. V., Kozlov A. P., Heimer R. The potential for bridging of HIV transmission in the Russian Federation: sex risk behaviors and HIV prevalence among drug users (DUs) and their non-DU sex partners. J Urban Health 2009; 86: s131-s143.
7. Krupitsky E., Zvartau E., Karandashova G., Horton N. J., Schoolwerth K. R., Bryant K. etal. The onset of HIV infection in the Leningrad region of Russia: a focus on drug and alcohol dependence. HIV Med 2004; 5: 30-3.
8. Karon J. M., Fleming P. L., Steketee R. W., De Cock K. M. HIV in the United States at the turn of the century: an epidemic in transition. Am J Public Health 2001; 91: 1060-8. PMCID:PMC1446722.
9. Wodak A., Maher L. The effectiveness of harm reduction in preventing HIV among injecting drug users. NSW Public Health Bull 2010; 21: 69-73.
10. Porter K., Wall P. G., Evans B. G. Factors associated with lack of awareness of HIV infection before diagnosis of AIDS. BMJ 1993; 307: 20-3. PMCID:PMC1678470.
11. Samet J. H., Retondo M. J., Freedberg K. A., Stein M. D., Heeren T., Libman H. Factors associated with initiation of primary medical care for HIV-infected persons. Am J Med 1994; 97: 347-53.
12. Mounier-Jack S., Nielsen S., Coker R. J. HIV testing strategies across European countries. HIV Med 2008; 9: 13-19.
13. Samet J. H., Freedberg K. A., Savetsky J. B., Sullivan L. M., Stein M. D. Understanding delay to medical care for HIV infection: the long-term non-presenter. AIDS 2001; 15: 77-85.
14. Bobrova N., Alcorn R., Rhodes T., Rughnikov I., Neifeld E., Power R. Injection drug users' perceptions of drug treatment services and attitudes toward substitution therapy: a qualitative study in three Russian cities. J Subst Abuse Treat 2007; 33: 373-8.
15. Samet J. H., Freedberg K. A., Stein M. D., Lewis R., Savetsky J., Sullivan L. etal. Trillion virion delay: time from testing positive for HIV to presentation for primary care. Arch Intern Med 1998; 158: 734-40.
16. Amirkhanian Y. A., Kelly J. A., Kuznetsova A. V., Difranceisco W. J., Musatov V. B., Pirogov D. G. People with HIV in HAART-era Russia: transmission risk behavior prevalence, antiretroviral medication-taking, and psychosocial distress. AIDS Behav 2010; 15: 767-77.
17. Wood E., Kerr T., Tyndall M. W., Montaner J. S. A review of barriers and facilitators of HIV treatment among injection drug users. AIDS 2008; 22: 1247-56.
18. Tkatchenko-Schmidt E., Atun R., Wall M., Tobi P., Schmidt J., Renton A. Why do health systems matter? Exploring links between health systems and HIV response: a case study from Russia. Health Policy Plan 2010; 25: 283-91.
19. Samet J. H., Krupitsky E. M., Cheng D. M., Raj A., Egorova V. Y., Levenson S. etal. Mitigating risky sexual behaviors among Russian narcology hospital patients: the PREVENT (Partnership to Reduce the Epidemic via Engagement in Narcology Treatment) randomized controlled trial. Addiction 2008; 103: 1474-83. PMCID:PMC2588416.